Filling a GAP(DH) in Caspase-Independent Cell Death  by Rathmell, Jeffrey C. & Kornbluth, Sally
observation suggests that either a 
Pax7-negative population of satellite 
cells is present in muscle or that some 
nonsatellite cells cofractionated with 
these marker combinations. We note 
also that the skeletal muscle specifi-
city of Myf5Cre has not been fully dem-
onstrated. Kuang and colleagues then 
demonstrated that the Pax7-positive 
satellite cells that lack Myf5 expression 
displayed a 3-fold greater engraftment 
potential than cells that express Myf5 
when transplanted into satellite-cell-
deficient Pax7 null mice. These find-
ings provide compelling evidence that 
the cells lacking Myf5 expression have 
a “stem-like” phenotype within the sat-
ellite cell population.
This study raises a number of 
intriguing questions. How is the 
choice between symmetric and asym-
metric divisions dictated in the satel-
lite cells that do not express Myf5? 
Can a more committed progenitor 
cell that expresses Myf5 still divide 
asymmetrically to yield, for example, 
one self-renewing and one irreversi-
bly committed daughter cell? It would 
also be interesting to measure the 
occurrence and frequency of asym-
metric perpendicular cell divisions in 
acutely or chronically diseased mus-
cle tissue, where the basal lamina is 
frequently and extensively destroyed. 
Future work may show that the main-
tenance of the stem cell pool during 
homeostasis or its depletion during 
aging or disease may depend on how 
these decisions are executed.
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Mitochondrial outer-membrane permeabilization can lead to cell death even without acti-
vation of caspases. In this issue of Cell, Colell et al. (2007) identify the glycolytic enzyme 
glyceraldehyde-3-phosphate dehydrogenase as a potent inhibitor of caspase-independent 
cell death that may allow metabolically active cells to survive mitochondrial insult.Apoptosis is a tidy form of cell 
death. The dying cell quietly com-
mits suicide without disturbing its 
neighbors and the corpse remains 
neatly packaged for clearance by 
phagocytes. This orderly dismantling 
of the apoptotic cell is the purview 
of caspases, enzymes that cleave 
cellular substrates, promoting the characteristic apoptotic morphol-
ogy. Caspase activation often results 
from mitochondrial outer-membrane 
permeabilization, triggered by a vari-
ety of apoptotic stimuli that promote 
release of proapoptotic mitochondrial 
contents including cytochrome c. 
Although pathways linking mitochon-
drial permeabilization and caspase Cell 12activation have received intense scru-
tiny, the oft-ignored truth is that mito-
chondrial permeabilization kills cells 
via a caspase-independent pathway if 
caspase activation is prevented. Nev-
ertheless, some cells can evade cas-
pase-independent cell death despite 
the blow to their mitochondria. In this 
issue, Colell et al. (2007) report the 9, June 1, 2007 ©2007 Elsevier Inc. 861
figure 1. GAPDH as a Regulator of caspase-Independent cell Death
GAPDH was identified in a genetic screen in which cells were infected with a retroviral cDNA 
library and treated with caspase inhibitors and staurosporine (STS), which leads to mitochondrial 
outer-membrane permeabilization. Surviving cell clones were cultured with staurosporine alone 
to identify those that specifically resisted caspase-independent cell death but were susceptible 
to apoptosis. The proposed mechanism for GAPDH-mediated resistance to caspase-independ-
ent cell death occurs through dual cytoplasmic and nuclear functions. In the cytoplasm, GAPDH 
promotes glucose metabolism to sustain cellular ATP levels. In the nucleus, GAPDH leads to 
induction of ATG12 expression, which enhances degradation of damaged mitochondria through 
autophagy.surprising discovery that the “house-
keeping” gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) 
plays a key role in opposing caspase-
independent death following release 
of mitochondrial cytochrome c.
Colell, Green, and their colleagues 
designed a clever screen for factors 
conferring survival only in cells that 
had undergone mitochondrial perme-
abilization in the absence of caspase 
activation, thereby avoiding repeated 
identification of established apop-
totic inhibitors that prevent permea-
bilization of the mitochondrial outer 
membrane (such as Bcl-2 proteins). 
They introduced a retroviral cDNA 
library into Jurkat cells treated with 
staurosporine, a potent inducer of 
mitochondrial outer-membrane per-
meabilization, and sought cell clones 
able to proliferate in the continued 
presence of a pan-caspase inhibi-
tor. Clones that also survived in the 
absence of caspase inhibitors were 
eliminated in a secondary screen (Fig-
ure 1). One can imagine the authors’ 
initial consternation when this screen 
yielded the ubiquitious glycolytic 
enzyme GAPDH. Nonetheless, they 
demonstrated that overexpression 
of GAPDH did not simply prevent 
mitochondrial permeabilization and 
did, indeed, confer protection against 
caspase-independent, but not cas-
pase-dependent, cell death. Fur-
thermore, GAPDH promoted survival 862 Cell 129, June 1, 2007 ©2007 Elseviein other scenarios of caspase-inde-
pendent cell death, most notably in 
cells expressing proapoptotic onco-
genes but lacking the cytochrome c-
binding partner, Apaf-1.
Given its glycolytic role, the isola-
tion of GAPDH suggested that main-
tenance of ATP levels might play a 
role in the escape from caspase-
independent death. Indeed, GAPDH 
expression conferred survival only in 
high-glucose media where GAPDH 
could increase intracellular ATP lev-
els. Despite these observations, the 
authors may have suspected that ATP 
was not the whole story when other 
metabolic enzymes did not emerge 
from their screen. Although it has a 
cytoplasmic “day job” in glycolysis, 
GAPDH also has roles in the nucleus 
(Sirover, 2005). Colell et al. (2007) 
therefore produced mutant variants 
of GAPDH that either retained the 
ability to translocate to the nucleus 
but were unable to support ATP pro-
duction, or variants that promoted 
ATP production but were unable to 
support nuclear functions. Remark-
ably, although neither of these mutant 
proteins could protect from caspase-
independent death, coexpression of 
both mutants promoted survival fol-
lowing mitochondrial permeabiliza-
tion/caspase inhibition.
As nuclear GAPDH has been impli-
cated in transcriptional regulation, 
the authors performed microarray r Inc.analysis to identify candidate genes 
induced by GAPDH expression. 
Interestingly, they identified ATG12, 
a known component of autophagic 
pathways (Tanida et al., 2004), dove-
tailing nicely with their observation 
that autophagy is increased in the 
cells expressing GAPDH. Moreover, 
ATG12 overexpression could substi-
tute for nuclear GAPDH in the com-
plementation assay described above, 
making it likely that increased ATP 
and enhanced ATG12 could coop-
erate to rescue cells from caspase-
independent death via autophagy. 
These findings suggest that ATG12 
can be rate limiting for the induc-
tion of autophagy, at least following 
mitochondrial permeabilization. It is 
unclear whether overexpression of 
ATG12 would also cooperate with 
other factors that elevate levels of 
ATP to rescue cells from caspase-
independent death. If GAPDH was 
the only clone identified from their 
initial screen, it may be because it 
is the only protein endowed with the 
dual ability to elevate ATP and induce 
ATG12 (Figure 1). Under physiological 
circumstances, it may be that expres-
sion of multiple genes attains similar 
results.
It is attractive to speculate that 
autophagy protects against caspase-
independent death through removal 
of damaged mitochondria. It is not 
clear whether the “recovery” of these 
cells (and the apparent ability of 
mitochondria to maintain membrane 
potential) is due to the proliferation 
of a small population of undamaged 
mitochondria or whether GAPDH 
expression also aids in the repair of 
damaged mitochondria. It will be of 
interest to monitor individual mito-
chondria within cells rescued from 
caspase-independent death to deter-
mine their fates.
It is important to consider how 
these findings apply to normal and 
disease physiology. Postmitotic 
cells, such as neurons and cardio-
myocytes, are resistant to cell death 
even after cytochrome c release and 
have been shown to downregulate 
Apaf-1 expression, thus prevent-
ing the formation of the caspase 
9/Apaf-1/cytochrome c apopto-
some complex, precluding caspase 
activation. Induction of inhibitor of 
apoptosis (IAP) proteins can also 
limit or prevent caspase activity fol-
lowing cytochrome c release (Wright 
and Deshmukh, 2006). Therefore, 
cells with alterations in these pro-
teins are candidates to survive even 
after mitochondrial permeabilization 
if caspase-independent death is 
inhibited. Nevertheless, mitochon-
dria that have released cytochrome 
c are functionally compromised even 
if caspase activity is prevented. In 
contrast to its assumed stability as 
a housekeeping protein, GAPDH can 
be highly regulated and may, under 
specific conditions, be induced suf-
ficiently to support viability of cells 
following mitochondrial permeabi-
lization. Lymphocyte stimulation, 
for example, has been known to 
strongly upregulate glycolysis and 
GAPDH (Sabath et al., 1990). For 
a cell with damaged mitochondria, 
enhanced glycolysis would pro-
vide a bioenergetic source and also 
promote nonmetabolic functions of 
GAPDH, such as the induction of 
ATG12. Thus GAPDH may promote 
survival of lymphocytes that suffer 
partial or complete mitochondrial 
permeabilization during encoun-
ters with cytotoxic pathogens or in 
the normal execution of an immune 
response. Consistent with this, 
Colell et al. (2007) note that T cells 
resistant to caspase activation due 
to mutation in cytochrome c have a 
memory phenotype, suggesting they 
had been activated at some point in 
their lifetime (Hao et al., 2005).The new work has demonstrated 
that a molecule considered by many 
to be among the most pedestrian of 
intracellular proteins can play a com-
plex role in cell fate. There remain, 
however, a number of significant 
issues and questions. First, is there 
some particular metabolic feature of 
GAPDH that is required? This question 
is highly relevant to the survival of can-
cer cells, which Otto Warburg showed 
in the 1920s are more glycolytic than 
their normal counterparts. Since then, 
it has been shown that many different 
proglycolytic genes can be upregu-
lated in cancer (Semenza et al., 2001). 
Although enhanced glycolysis can 
provide some initial protection from 
mitochondrial permeabilization and 
cytochrome c release (Gottlob et 
al., 2001; Zhao et al., 2007), it is not 
clear whether it affects the caspase-
independent cell pathway after mito-
chondrial permeabilization. As many 
cancers carry mutations that impair 
cytochrome c-induced caspase acti-
vation, GAPDH overexpression may 
assist cancer cells in evading apop-
tosis, particularly when induced by 
chemotherapeutics that promote 
mitochondrial permeabilization.
How does GAPDH lead to ATG12 
upregulation? There are a number 
of studies documenting nonmeta-
bolic functions of GAPDH and Colell 
et al. (2007) provide fresh impe-
tus to revisit these nontraditional 
roles. Autophagy can promote cell 
survival and function in tumor sup-
pression. What allows autophagy to 
clear damaged mitochondria while 
preserving intact organelles thus aid-Cell 12ing survival? Lastly, how frequently 
does the circumstance of inhibited 
caspase activity, elevated glyco-
lysis, and autophagy occur in vivo? 
Clearly, there are instances when 
these events coincide, but is elevated 
GAPDH expression essential? This 
is an important and fertile ground 
for additional study as researchers 
consider how expression of this tra-
ditional gel-loading control may be 
regulated and how this may influence 
the fate of their favorite cells.
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